Triamcinolone acetonide

XIPERE™ (triamcinolone acetonide injectable suspension) is approved by FDA for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis

LAVAL, QC and ALPHARETTA, Ga., Oct. 25, 2021 Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), and Clearside Biomedical, Inc. (Nasdaq: CLSD) ("Clearside"), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), today announced that…